6-24290975-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000378454.8(DCDC2):āc.661A>Gā(p.Ser221Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.642 in 1,613,216 control chromosomes in the GnomAD database, including 344,434 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S221N) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000378454.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCDC2 | NM_016356.5 | c.661A>G | p.Ser221Gly | missense_variant | 5/10 | ENST00000378454.8 | NP_057440.2 | |
DCDC2 | NM_001195610.2 | c.661A>G | p.Ser221Gly | missense_variant | 6/11 | NP_001182539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCDC2 | ENST00000378454.8 | c.661A>G | p.Ser221Gly | missense_variant | 5/10 | 1 | NM_016356.5 | ENSP00000367715 | P1 |
Frequencies
GnomAD3 genomes AF: 0.525 AC: 79752AN: 151970Hom.: 25451 Cov.: 32
GnomAD3 exomes AF: 0.654 AC: 164087AN: 251070Hom.: 56707 AF XY: 0.660 AC XY: 89646AN XY: 135726
GnomAD4 exome AF: 0.654 AC: 955781AN: 1461128Hom.: 318979 Cov.: 43 AF XY: 0.656 AC XY: 476950AN XY: 726906
GnomAD4 genome AF: 0.524 AC: 79758AN: 152088Hom.: 25455 Cov.: 32 AF XY: 0.535 AC XY: 39747AN XY: 74344
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 13, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Isolated neonatal sclerosing cholangitis Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Autosomal recessive nonsyndromic hearing loss 66;C4479344:Isolated neonatal sclerosing cholangitis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Autosomal recessive nonsyndromic hearing loss 66 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Nephronophthisis 19 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at